Controlling exit site infections: Does it decrease the incidence of catheter-related bacteremia in children on chronic hemodialysis?

Hemodialysis International

Volumn 13, Issue 1, 2009, Pages 11-18

  Onder, Ali Mirza ^a,c   Chandar, Jayanthi ^b   Coakley, Sheila ^b   Francoeur, Denise ^b   Abitbol, Carolyn ^b   Zilleruelo, Gaston ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Betadine; Biopatch ; Catheter survival; Catheter related bacteremia; Chlorhexidine; Exit site infection; Sepsis

Indexed keywords

CEFOTAXIME; CHLORHEXIDINE; LEVOFLOXACIN; OXACILLIN; POVIDONE IODINE; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CATHETER INFECTION; CHILD; CONTROLLED STUDY; DIALYSIS CATHETER; FEMALE; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TRANSPARENT DRESSING;

ADOLESCENT; BACTEREMIA; BANDAGES; CATHETER-RELATED INFECTIONS; CHILD; CHLORHEXIDINE; FEMALE; HUMANS; MALE; POVIDONE-IODINE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 59249108813     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00348.x     Document Type: Article

References (29)

1. Powe NR, Jaar B, Furth SL. Septicemia in dialysis patients: Incidence, risk factors and prognosis. Kidney Int. 1999; 55: 1081-1090.
2. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999; 34: 1114-1124.
3. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998; 9: 869-876.
4. Onder AM, Chandar J, Saint-Vil M, Lopez-Mitnik G, Abitbol CL, Zilleruelo G. Catheter survival and comparison of catheter exchange methods in children on hemodialysis. Pediatr Nephrol. 2007; 22: 1355-1361.
5. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron. 1993; 64: 95-100.
6. Hodge D, Puntis JWL. Diagnosis, prevention, and management of catheter-related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatel Ed. 2002; 87: F21-F24.
7. Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis. 1986; 154: 579-589.
8. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaisse E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993; 168: 400-407.
9. Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol. 1985; 21: 357-360.
10. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 1991; 40: 934-938.
11. Johnson DW, MacGinley R, Kay TD, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunneled, cuffed hemodialysis catheters. Nephrol Dial Transplant. 2002; 17: 1802-1807.
12. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003; 14: 169-179.
13. Maki DG, Mermel LA, Kluger D, Narins L, Knasinski V, Parenteau S. The efficacy of a chlorhexidine-impregnated sponge (Biopatch ™) for the prevention of intravascular catheter-related infection: A prospective, randomized, controlled, multicenter study. Abstract 1430. In: Ferric C. Fang, Robert T. Schooley, David A. Relman, eds. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto Canada. Washington, DC: American Society for Microbiology; 2000: Pp. 422-424.
14. Crawford AG, Fuhr JP, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hops Epidemiol. 2004; 25: 668-674.
15. NKF K/DOQI Guidelines Clinical Practice Guidelines for Vascular Access, 2006 Update Available from: http://www.kidney.org (accessed date: December 2, 2007).
16. O'Grady NP, Alexander M, Dellinger EP, et al. Healthcare Infection Control Practices Advisory Committee: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2002; 30: 476-489.
17. Krein SL, Hofer TP, Kowalski CP, et al. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc. 2007; 82: 672-678.
18. Alv R, Marlbach HI. Effect of antimicrobial soap containing chlorhexidine on the microbial flora of skin. Appl Environ Microbiol. 1976; 31: 931-935.
19. Shelton DM. A comparison of the effects of two antiseptic agents on staphylococcus epidermidis colony forming units at the peritoneal dialysis catheter exit site. Adv Perit Dial. 1991; 7: 120-124.
20. Bhende S, Spangler D. In vitro assessment of chlorhexidine gluconate-impregnated polyurethane foam antimicrobial dressing using zone of inhibition assays. Infect Control Hosp Epidemiol. 2004; 25: 664-667.
21. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001; 107: 1431-1436.
22. Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children. Pediatr Infect Dis J. 2005; 24: 676-679.
23. Ho KW, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: A meta-analysis. J Antimicrob Chemother. 2006; 58: 281-287.
24. Roberts B, Cheung D. Biopatch-a new concept in antimicrobial dressings for invasive devices. Aust Crit Care. 1998; 11: 16-19.
25. Chambers ST, Sanders J, Patton WN, et al. Reduction of exit-site infections of tunneled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: Results from a prospective randomized trial. J Hosp Infect. 2005; 61: 53-61.
26. Onder AM, Chandar J, Coakley S, Abitbol C, Montane B, Zilleruelo G. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis. Pediatr Nephrol. 2006; 21: 1452-1458.
27. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004; 30: 62-67.
28. Rosenbaum D, MacRae JM, Djurdjev O, Levin A, Werb R, Kiaii M. Surveillance cultures of tunneled cuffed catheter exit sites in chronic hemodialysis patients are of no benefit. Hemodial Int. 2006; 10: 365-370.
29. Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment. J Am Soc Nephrol. 1998; 9: 1085-1092.